References
- Piel FB, Weatherall DJ. The alpha-thalassemias. N Engl J Med. 2014;371(20):1908–1916. doi: 10.1056/NEJMra1404415.
- Giardine BM, Joly P, Pissard S, et al. Clinically relevant updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res. 2021;49(D1):D1192–D1196. doi: 10.1093/nar/gkaa959.
- He J, Song W, Yang J, et al. Next-generation sequencing improves thalassemia carrier screening among premarital adults in a high prevalence population: the Dai nationality, China. Genet Med. 2017;19(9):1022–1031. doi: 10.1038/gim.2016.218.
- Kountouris P, Lederer CW, Fanis P, et al. IthaGenes: an interactive database for haemoglobin variations and epidemiology. PLoS One. 2014;9(7):e103020. doi: 10.1371/journal.pone.0103020.
- Farashi S, Harteveld CL. Molecular basis of alpha-thalassemia. Blood Cells Mol Dis. 2018;70:43–53. doi: 10.1016/j.bcmd.2017.09.004.
- Wajcman H, Traeger-Synodinos J, Papassotiriou I, et al. Unstable and thalassemic alpha chain hemoglobin variants: a cause of Hb H disease and thalassemia intermedia. Hemoglobin. 2008;32(4):327–349. doi: 10.1080/03630260802173833.
- Khajavi M, Inoue K, Lupski JR. Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease. Eur J Hum Genet. 2006;14(10):1074–1081. doi: 10.1038/sj.ejhg.5201649.
- Qadah T, Finlayson J, North E, et al. Molecular characterization of Hb Hamilton Hill (HBA2: c.388delC), a novel HBA2 variant generating a premature termination codon and truncated HBA2 chain. Hemoglobin. 2015;39(2):88–94. doi: 10.3109/03630269.2015.1016958.
- Grimholt RM, Fjeld B, Klingenberg O. Hemoglobinopathy gone astray-three novel forms of alpha-thalassemia in Norwegian patients characterized by quantitative real-time PCR and DNA sequencing. Scand J Clin Lab Invest. 2021;81(8):670–678. doi: 10.1080/00365513.2021.2004218.
- Kalle Kwaifa I, Lai MI, Md Noor S. Non-deletional alpha thalassaemia: a review. Orphanet J Rare Dis. 2020;15(1):166. doi: 10.1186/s13023-020-01429-1.
- Finlayson J, Ghassemifar R, Holmes P, et al. Hb Lynwood [alpha107(G14) (-T) (alpha2) HBA2:c.323delT)] in conjunction with the alpha(3.7) deletion produces a moderately severe alpha-thalassemia phenotype. Hemoglobin. 2011;35(2):142–146. doi: 10.3109/03630269.2011.557462.
- Suhaimi SA, Zulkipli IN, Ghani H, et al. Applications of next generation sequencing in the screening and diagnosis of thalassemia: a mini-review. Front Pediatr. 2022;10:1015769. doi: 10.3389/fped.2022.1015769.